143 related articles for article (PubMed ID: 7913543)
1. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
[TBL] [Abstract][Full Text] [Related]
2. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
Ghysdael J; Beug H
Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
[TBL] [Abstract][Full Text] [Related]
3. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
Schroeder C; Gibson L; Beug H
Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
[TBL] [Abstract][Full Text] [Related]
4. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder C; Gibson L; Zenke M; Beug H
Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
[TBL] [Abstract][Full Text] [Related]
5. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
Sharif M; Privalsky ML
Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
7. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
8. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of avian myoblast differentiation by triiodothyronine: possible involvement of the cAMP pathway.
Marchal S; Cassar-Malek I; Magaud JP; Rouault JP; Wrutniak C; Cabello G
Exp Cell Res; 1995 Sep; 220(1):1-10. PubMed ID: 7664826
[TBL] [Abstract][Full Text] [Related]
10. Changes in mitochondrial activity during avian myoblast differentiation: influence of triiodothyronine or v-erb A expression.
Rochard P; Cassar-Malek I; Marchal S; Wrutniak C; Cabello G
J Cell Physiol; 1996 Aug; 168(2):239-47. PubMed ID: 8707859
[TBL] [Abstract][Full Text] [Related]
11. c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.
Gandrillon O; Ferrand N; Michaille JJ; Roze L; Zile MH; Samarut J
Oncogene; 1994 Mar; 9(3):749-58. PubMed ID: 7906409
[TBL] [Abstract][Full Text] [Related]
12. Opposing functions of ATF2 and Fos-like transcription factors in c-Jun-mediated myogenin expression and terminal differentiation of avian myoblasts.
Daury L; Busson M; Tourkine N; Casas F; Cassar-Malek I; Wrutniak-Cabello C; Castellazzi M; Cabello G
Oncogene; 2001 Nov; 20(55):7998-8008. PubMed ID: 11753683
[TBL] [Abstract][Full Text] [Related]
13. BTG1: a triiodothyronine target involved in the myogenic influence of the hormone.
Rodier A; Marchal-Victorion S; Rochard P; Casas F; Cassar-Malek I; Rouault JP; Magaud JP; Mason DY; Wrutniak C; Cabello G
Exp Cell Res; 1999 Jun; 249(2):337-48. PubMed ID: 10366433
[TBL] [Abstract][Full Text] [Related]
14. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
15. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
16. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line.
Iglesias T; Llanos S; López-Barahona M; Pérez-Aranda A; Rodríguez-Peña A; Bernal J; Höhne A; Seliger B; Muñoz A
Cell Growth Differ; 1994 Jul; 5(7):697-704. PubMed ID: 7947384
[TBL] [Abstract][Full Text] [Related]
17. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-erbA proto-oncogene enhances myogenic differentiation.
Carnac G; Albagli-Curiel O; Desclozeaux M; Vandromme M; Glineur C; Bègue A; Laudet V; Bonnieu A
Oncogene; 1993 Nov; 8(11):3103-10. PubMed ID: 8414512
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the cell-specific activity of v-erb A in quail myoblasts.
Cassar-Malek I; Marchal S; Rochard P; Wrutniak C; Samarut J; Cabello G
Oncogene; 1997 Mar; 14(9):1099-108. PubMed ID: 9070659
[TBL] [Abstract][Full Text] [Related]
20. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
Metz T; Graf T
Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
